MXPA03007332A - Levothyroxine compositions and methods. - Google Patents

Levothyroxine compositions and methods.

Info

Publication number
MXPA03007332A
MXPA03007332A MXPA03007332A MXPA03007332A MXPA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A
Authority
MX
Mexico
Prior art keywords
methods
compositions
sodium
making
levothyroxine
Prior art date
Application number
MXPA03007332A
Other languages
Spanish (es)
Inventor
A Dimenna Philip
Original Assignee
King Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Inc filed Critical King Pharmaceuticals Inc
Priority claimed from PCT/US2002/004665 external-priority patent/WO2003070217A1/en
Publication of MXPA03007332A publication Critical patent/MXPA03007332A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
MXPA03007332A 2001-02-15 2002-02-15 Levothyroxine compositions and methods. MXPA03007332A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26900901P 2001-02-15 2001-02-15
US26899801P 2001-02-15 2001-02-15
PCT/US2002/004665 WO2003070217A1 (en) 2002-02-15 2002-02-15 Levothyroxine compositions and methods

Publications (1)

Publication Number Publication Date
MXPA03007332A true MXPA03007332A (en) 2005-11-10

Family

ID=28044645

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007332A MXPA03007332A (en) 2001-02-15 2002-02-15 Levothyroxine compositions and methods.

Country Status (4)

Country Link
AU (1) AU2002240394A1 (en)
BR (1) BR0207299A (en)
MX (1) MXPA03007332A (en)
NO (1) NO20033636L (en)

Also Published As

Publication number Publication date
BR0207299A (en) 2005-02-09
AU2002240394A1 (en) 2003-09-09
NO20033636L (en) 2003-10-15
NO20033636D0 (en) 2003-08-15

Similar Documents

Publication Publication Date Title
HK1096034A1 (en) A solid dosage form comprising a fibrate
BG66093B1 (en) Controlled release compositions comprising nimesulide
PT1412384E (en) Stable formulation of modified glp-1
BR0003158A (en) Instant melting oral dosage formulation
TNSN01130A1 (en) EXTENDED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGUES
MY151468A (en) Controlled release solid preparation
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
IL153297A0 (en) Compounds and compositions for delivering active agents
PT893992E (en) FORMS OF FAST DISINTEGRATION ORAL DOSAGE
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
GEP20053473B (en) High Potency Dihydroergotamine Compositions
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
MX2009003030A (en) Galenic form for the trans-mucosal delivery of active ingredients.
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
ES2110212T3 (en) EFFERVESCENT PHARMACEUTICAL COMPOSITION CONTAINING IBUPROPHEN AND ITS PREPARATION PROCEDURE.
MXPA03007857A (en) Compounds and compositions for delivering active agents.
AP2003002763A0 (en) Controlled release formulations for oral administration
MX2010004556A (en) Pharmaceutical formulation of clavulanic acid.
HK1022265A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
WO2003028624A3 (en) Levothyroxine compositions and methods
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
NO20023551D0 (en) Ibuprofen-containing active agent preparation
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
CY1107295T1 (en) STABILIZATION OF SOLID FORMULON MEDICATIONS FOR THYROID
BR0209155A (en) Pharmaceutical tablet having a high api content